CSL Behring evaluates monoclonal Ab for respiratory distress
Australia | News | 0 Comment | 08 Jul, 2020
Australia based CSL Limited's part, CSL Behring has announced that the first patient has been enrolled in its ...Read more
Affinity discovers potent SARS-CoV-2 antibodies
Australia | News | 0 Comment | 03 Jul, 2020
Melbourne-based Affinity Biosciences Pty Ltd (Affinity), a privately held company focused on antibody discovery for canc...Read more
Australia starts new projects to deal with drug resistance
Australia | News | 0 Comment | 02 Jul, 2020
Australia’s commitment to support the health and wellbeing of the Pacific Island neighbours remains steadfast, wit...Read more
Australia invests $19M in AI health research projects
Australia | News | 0 Comment | 01 Jul, 2020
The Australian Government is investing $19 million in transformative medical research projects using game-changing appli...Read more
Alterity meets US FDA for ATH434 pathway to treat Multiple System Atrophy
Australia | News | 0 Comment | 30 Jun, 2020
Alterity Therapeutics announced that it has received guidance from the US Food and Drug Administration (FDA) in relation...Read more
Australia to study first interventional neuromodulation platform
Australia | News | 0 Comment | 29 Jun, 2020
US based Synchron Inc., a neurovascular bioelectronic medicine company, has announced that the University of Melbou...Read more
Neoteryx gets blood collection device registered in Australia
Australia | News | 0 Comment | 30 Jun, 2020
The Mitra® microsampling device from US company Neoteryx has been registered as a Class I in vitro diagnostic (IVD) ...Read more
Australia pitches $12M more for CVD research
Australia | News | 0 Comment | 26 Jun, 2020
The Australian government, together with the National Heart Foundation, is announcing a further $12 million for research...Read more
Australia invests over $5.7M in traumatic brain injury research
Australia | News | 0 Comment | 25 Jun, 2020
The Australian Government is investing over $5.7 million to further develop traumatic brain injury research, aimed at im...Read more
Cardiovascular disease (CVD) impact on Asia-Pacific markets
Australia | Analysis | 2 Comment | 23 Jun, 2020
HONG KONG Prevalence CVD, including heart attack and stroke, is the third leading cause of death in Hong Kong (aft...Read more
EIU launches APAC Economist Intelligence Unit report for heart ailments
Australia | News | 0 Comment | 23 Jun, 2020
The Cost of Inaction: Secondary Prevention of Cardiovascular Disease in Asia-Pacific Rehabilitation ...Read more
Clover Biopharma initiates Ph 1 trial for COVID-19 vaccine
Australia | News | 0 Comment | 22 Jun, 2020
Clover Biopharmaceuticals, headquartered in China, has announced that the first participants have been dosed in the Phas...Read more
Australia uses digital tools for personalised health support
Australia | News | 0 Comment | 19 Jun, 2020
Treatment effectiveness, health care costs and quality of life outcomes for the two to four percent of Australians with ...Read more
Australia approves novel medical device to treat chronic back pain
Australia | News | 1 Comment | 18 Jun, 2020
Medical professionals will soon have access to a new device to treat the 3.24 million Australians who suffer chronic pai...Read more
SpeeDx, Roche to expand access to antibiotic resistance tests
Australia | News | 0 Comment | 17 Jun, 2020
Australia based SpeeDx, a developer of innovative molecular diagnostic solutions, has partnered with Roche, a global pio...Read more
TrialTrove Data Shows Australia is Open for Business says Avance Clinical
Australia | News | 0 Comment | 10 Jun, 2020
The leading Australian CRO for biotechs, Avance Clinical announced at BIO Digital on 10 June 2020 that Australia current...Read more
Atomo and NG Biotech expand COVID-19 partnership
Australia | News | 0 Comment | 10 Jun, 2020
Australian firm Atomo Diagnostics Limited is pleased to announce it has expanded its existing COVID-19 rapid test p...Read more
Novavax receives $60m from DOD to secure 10 million COVID-19 vaccine doses
Australia | News | 0 Comment | 07 Jun, 2020
Novavax commenced Phase I clinical trial for their COVID-19 vaccine "NVX-CoV2373" a stable prefusion protein antige...Read more